Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Corvus' China partner Angel approved by China regulator to begin TCL study » 16:57
10/27/21
10/27
16:57
10/27/21
16:57
CRVS

Corvus Pharmaceuticals

$4.55 /

+0.095 (+2.13%)

Corvus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRVS Corvus Pharmaceuticals
$4.55 /

+0.095 (+2.13%)

CRVS Corvus Pharmaceuticals
$4.55 /

+0.095 (+2.13%)

09/22/21 Roth Capital
Corvus recent rally due to AstraZeneca data, says Roth Capital
08/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target lowered to $5 from $10 at Cantor Fitzgerald
08/03/21 Mizuho
Corvus Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
07/16/21 H.C. Wainwright
Corvus Pharmaceuticals price target lowered to $6 from $9.50 at H.C. Wainwright
CRVS Corvus Pharmaceuticals
$4.55 /

+0.095 (+2.13%)

  • 12
    Feb
CRVS Corvus Pharmaceuticals
$4.55 /

+0.095 (+2.13%)

CRVS Corvus Pharmaceuticals
$4.55 /

+0.095 (+2.13%)

On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:55
10/27/21
10/27
16:55
10/27/21
16:55
GOOG

Alphabet

$2,929.05 /

+132.96 (+4.76%)

, GOOGL

Alphabet Class A

$2,925.66 /

+136.025 (+4.88%)

, MSFT

Microsoft

$323.14 /

+13.3 (+4.29%)

, KO

Coca-Cola

$55.51 /

+1.05 (+1.93%)

, RDS.A

Royal Dutch Shell

$49.94 /

+1.09 (+2.23%)

, RDS.B

Royal Dutch Shell

$49.68 /

+0.645 (+1.32%)

, RENT

Rent The Runway

$19.10 /

-3.9 (-16.96%)

, NET

Cloudflare

$178.59 /

-6.62 (-3.57%)

, ETSY

Etsy

$243.86 /

-4 (-1.61%)

, UPS

UPS

$212.16 /

-5.9 (-2.71%)

, RDBX

Redbox

$15.59 /

-0.26 (-1.64%)

, TSLA

Tesla

$1,038.00 /

+20 (+1.96%)

, HTZZ

Hertz

$27.01 /

-0.44 (-1.60%)

, FB

Facebook

$312.23 /

-3.47 (-1.10%)

, GM

General Motors

$54.25 /

-3.13 (-5.45%)

, AMZN

Amazon.com

$3,393.47 /

+19.55 (+0.58%)

, DWAC

Digital World Acquisition

$64.85 /

+6.1 (+10.38%)

, V

Visa

$215.78 /

-15.92 (-6.87%)

, PYPL

PayPal

$234.89 /

-8.11 (-3.34%)

, SQ

Square

$253.09 /

-10.54 (-4.00%)

, ENPH

Enphase Energy

$216.29 /

+42.83 (+24.69%)

, HOG

Harley-Davidson

$36.73 /

+1.23 (+3.46%)

, MAS

Masco

$64.26 /

+3.13 (+5.12%)

, CRTX

Cortexyme

$13.31 /

-44.24 (-76.87%)

, STNE

StoneCo

$33.84 /

-2.61 (-7.16%)

, PAGS

PagSeguro Digital

$36.10 /

-2.65 (-6.84%)

, NYCB

New York Community Bancorp

$12.82 /

-1.125 (-8.07%)

, FISV

Fiserv

$98.86 /

-10.995 (-10.01%)

, ALKS

Alkermes

$28.63 /

-2.89 (-9.17%)

, SIX

Six Flags

$42.28 /

-3.83 (-8.31%)

, HOOD

Robinhood

$35.43 /

-4.28 (-10.78%)

, TWTR

Twitter

$54.80 /

-6.735 (-10.95%)

, BA

Boeing

$206.57 /

-3.195 (-1.52%)

, MCD

McDonald's

$242.87 /

+6.455 (+2.73%)

Get caught up quickly on…

ShowHide Related Items >><<
V Visa
$215.78 /

-15.92 (-6.87%)

UPS UPS
$212.16 /

-5.9 (-2.71%)

TWTR Twitter
$54.80 /

-6.735 (-10.95%)

TSLA Tesla
$1,038.00 /

+20 (+1.96%)

STNE StoneCo
$33.84 /

-2.61 (-7.16%)

SQ Square
$253.09 /

-10.54 (-4.00%)

SIX Six Flags
$42.28 /

-3.83 (-8.31%)

RDS.B Royal Dutch Shell
$49.68 /

+0.645 (+1.32%)

RDS.A Royal Dutch Shell
$49.94 /

+1.09 (+2.23%)

RDBX Redbox
$15.59 /

-0.26 (-1.64%)

PYPL PayPal
$234.89 /

-8.11 (-3.34%)

PAGS PagSeguro Digital
$36.10 /

-2.65 (-6.84%)

NYCB New York Community Bancorp
$12.82 /

-1.125 (-8.07%)

NET Cloudflare
$178.59 /

-6.62 (-3.57%)

MSFT Microsoft
$323.14 /

+13.3 (+4.29%)

MCD McDonald's
$242.87 /

+6.455 (+2.73%)

MAS Masco
$64.26 /

+3.13 (+5.12%)

KO Coca-Cola
$55.51 /

+1.05 (+1.93%)

HTZZ Hertz
$27.01 /

-0.44 (-1.60%)

HOOD Robinhood
$35.43 /

-4.28 (-10.78%)

HOG Harley-Davidson
$36.73 /

+1.23 (+3.46%)

GOOG Alphabet
$2,929.05 /

+132.96 (+4.76%)

GM General Motors
$54.25 /

-3.13 (-5.45%)

FISV Fiserv
$98.86 /

-10.995 (-10.01%)

FB Facebook
$312.23 /

-3.47 (-1.10%)

ETSY Etsy
$243.86 /

-4 (-1.61%)

ENPH Enphase Energy
$216.29 /

+42.83 (+24.69%)

DWAC Digital World Acquisition
$64.85 /

+6.1 (+10.38%)

CRTX Cortexyme
$13.31 /

-44.24 (-76.87%)

BA Boeing
$206.57 /

-3.195 (-1.52%)

AMZN Amazon.com
$3,393.47 /

+19.55 (+0.58%)

ALKS Alkermes
$28.63 /

-2.89 (-9.17%)

GOOG Alphabet
$2,929.05 /

+132.96 (+4.76%)

09:15 Today Wedbush
Alphabet Class A price target raised to $3,530 from $3,424 at Wedbush
08:40 Today Jefferies
Alphabet price target raised to $3,500 from $3,325 at Jefferies
08:37 Today Credit Suisse
Alphabet Class A price target raised to $3,450 from $3,400 at Credit Suisse
08:28 Today Wells Fargo
Alphabet Class A price target raised to $3,400 from $3,100 at Wells Fargo
GOOGL Alphabet Class A
$2,925.66 /

+136.025 (+4.88%)

09:53 Today BMO Capital
Alphabet target raised to $3,200 from $3,000 at BMO Capital
MSFT Microsoft
$323.14 /

+13.3 (+4.29%)

09:13 Today Wedbush
Microsoft delivers another 'World-Series' cloud performance, says Wedbush
08:41 Today Credit Suisse
Microsoft price target raised to $340 from $320 at Credit Suisse
08:33 Today Morgan Stanley
Microsoft price target raised to $364 from $331 at Morgan Stanley
08:24 Today Evercore ISI
Microsoft price target raised to $370 from $325 at Evercore ISI
KO Coca-Cola
$55.51 /

+1.05 (+1.93%)

10/15/21 Deutsche Bank
Coca-Cola price target lowered to $59 from $60 at Deutsche Bank
09/21/21 Guggenheim
PepsiCo price target raised to $175 from $171 at Guggenheim
07/22/21 Truist
Coca-Cola price target raised to $65 from $60 at Truist
07/22/21 Deutsche Bank
Coca-Cola price target raised to $60 from $58 at Deutsche Bank
RDS.A Royal Dutch Shell
$49.94 /

+1.09 (+2.23%)

10/25/21 Citi
Royal Dutch Shell price target raised to 1,710 GBp from 1,430 GBp at Citi
10/25/21 TD Securities
BP initiated with a Hold at TD Securities
10/25/21 TD Securities
Royal Dutch Shell initiated with a Buy at TD Securities
10/12/21 Morgan Stanley
Royal Dutch Shell price target raised to 2,089 GBp at Morgan Stanley
RDS.B Royal Dutch Shell
$49.68 /

+0.645 (+1.32%)

10/11/21 JPMorgan
Royal Dutch Shell price target raised to 2,300 GBp from 2,150 GBp at JPMorgan
09/23/21 JPMorgan
Royal Dutch Shell price target raised to 2,150 GBp from 2,100 GBp at JPMorgan
09/21/21 Credit Suisse
ConocoPhillips price target raised to $80 from $74 at Credit Suisse
09/17/21 JPMorgan
Royal Dutch Shell price target lowered to 2,100 GBp from 2,200 GBp at JPMorgan
RENT Rent The Runway
$19.10 /

-3.9 (-16.96%)

NET Cloudflare
$178.59 /

-6.62 (-3.57%)

09:55 Today
Fly Intel: Top five analyst downgrades
04:48 Today Jefferies
Cloudflare downgraded to Hold from Buy at Jefferies
10/25/21 Truist
Cloudflare price target raised to $185 from $130 at Truist
10/19/21 Cowen
Cloudflare price target raised to $200 from $135 at Cowen
ETSY Etsy
$243.86 /

-4 (-1.61%)

09:55 Today
Fly Intel: Top five analyst initiations
08:15 Today Argus
Etsy initiated with a Hold at Argus
08:04 Today Argus
Etsy initiated with a Hold at Argus
10/25/21 Wedbush
Etsy price target raised to $264 from $195 at Wedbush
UPS UPS
$212.16 /

-5.9 (-2.71%)

07:47 Today Raymond James
UPS price target raised to $260 from $240 at Raymond James
07:44 Today KeyBanc
UPS price target raised to $250 from $235 at KeyBanc
07:37 Today Oppenheimer
UPS price target raised to $236 from $222 at Oppenheimer
RDBX Redbox
$15.59 /

-0.26 (-1.64%)

08:01 Today B. Riley
B. Riley starts Redbox with Buy, sees 'meaningful upside potential'
05:06 Today B. Riley
Redbox initiated with a Buy at B. Riley
TSLA Tesla
$1,038.00 /

+20 (+1.96%)

09:30 Today Wedbush
Other bulk deals to follow and further benefit Tesla, says Wedbush
07:25 Today Goldman Sachs
Goldman ups Tesla target to $1,125 after 'important' Hertz order
10/25/21 Wedbush
Hertz mega deal another 'feather in the cap' for Tesla, says Wedbush
10/25/21 Morgan Stanley
Tesla price target raised to $1,200 from $900 at Morgan Stanley
HTZZ Hertz
$27.01 /

-0.44 (-1.60%)

10:24 Today William Blair
Deal with Hertz could 'meaningfully' boost Carvana sales, says William Blair
FB Facebook
$312.23 /

-3.47 (-1.10%)

07:16 Today Bernstein
Google wins 'hide and seek,' says Bernstein
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
GM General Motors
$54.25 /

-3.13 (-5.45%)

15:28 Today Citi
GM share price reaction to guidance 'looks excessive,' says Citi
10/22/21 Barclays
General Motors price target raised to $70 from $68 at Barclays
AMZN Amazon.com
$3,393.47 /

+19.55 (+0.58%)

10/25/21 Wedbush
E-commerce share gains, advertiser demand to drive Amazon Q3 beat, says Wedbush
10/22/21 Credit Suisse
Amazon price target lowered to $4,200 from $4,700 at Credit Suisse
10/21/21 Baird
Amazon executive commentary on supply chain 'largely positive,' says Baird
10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
DWAC Digital World Acquisition
$64.85 /

+6.1 (+10.38%)

V Visa
$215.78 /

-15.92 (-6.87%)

09:43 Today RBC Capital
Visa price target lowered to $284 from $297 at RBC Capital
07:51 Today JPMorgan
Visa price target raised to $277 from $267 at JPMorgan
07:49 Today Raymond James
Visa price target lowered to $263 from $286 at Raymond James
09/03/21 Morgan Stanley
Visa interchange risk from Amazon will pass, says Morgan Stanley
PYPL PayPal
$234.89 /

-8.11 (-3.34%)

10/21/21 Credit Suisse
Rationale for acquiring Pinterest vs. partnership less clear, says Credit Suisse
10/21/21 Deutsche Bank
Deutsche 'intrigued' by strategic possibilities of PayPal buying Pinterest
10/20/21 Bernstein
PayPayl, Pinterest 'is a match NOT made in heaven,' says Bernstein
10/20/21 Keefe Bruyette
Pinterest purchase 'can make sense' for PayPal, says Keefe Bruyette
SQ Square
$253.09 /

-10.54 (-4.00%)

10/21/21 Barclays
Square price target lowered to $325 from $345 at Barclays
10/20/21 Truist
PayPal deal for Pinterest would make 'zero sense,' says Truist
10/18/21 BofA
BofA ups Square target to $210 but maintains sell rating
10/12/21
Fly Intel: Top five analyst upgrades
ENPH Enphase Energy
$216.29 /

+42.83 (+24.69%)

08:58 Today Craig-Hallum
Enphase Energy price target raised to $186 from $175 at Craig-Hallum
08:53 Today Truist
Enphase Energy price target raised to $250 from $205 at Truist
08:08 Today B. Riley
Enphase Energy price target raised to $180 from $157 at B. Riley
07:52 Today JPMorgan
Enphase Energy price target raised to $247 from $238 at JPMorgan
HOG Harley-Davidson
$36.73 /

+1.23 (+3.46%)

09/10/21 Tigress Financial
Harley-Davidson shares have 47% upside potential, says Tigress Financial
09/09/21 Wedbush
Harley-Davidson price target lowered to $54 from $60 at Wedbush
07/27/21 Edward Jones
Harley-Davidson downgraded to Sell from Hold at Edward Jones
07/22/21 Baird
Harley-Davidson demand drove inventory down, says Baird
MAS Masco
$64.26 /

+3.13 (+5.12%)

10/04/21 Loop Capital
Masco price target lowered to $60 from $63 at Loop Capital
07/15/21 Wells Fargo
Masco initiated with an Overweight at Wells Fargo
07/15/21 Barclays
Masco price target lowered to $62 from $64 at Barclays
07/07/21
Fly Intel: Top five analyst downgrades
CRTX Cortexyme
$13.31 /

-44.24 (-76.87%)

07:10 Today Canaccord
Cortexyme price target lowered to $75 from $150 at Canaccord
06:35 Today BofA
Cortexyme downgraded to Underperform at BofA after Alzheimer's trial miss
06:29 Today BofA
Cortexyme downgraded to Underperform from Neutral at BofA
STNE StoneCo
$33.84 /

-2.61 (-7.16%)

10/18/21 Susquehanna
StoneCo price target lowered to $65 from $90 at Susquehanna
09/03/21 HSBC
StoneCo price target lowered to $65 from $85 at HSBC
08/31/21 Evercore ISI
StoneCo price target lowered to $84 from $100 at Evercore ISI
08/25/21 BofA
StoneCo press release indicates miss in upcoming Q2, says BofA
PAGS PagSeguro Digital
$36.10 /

-2.65 (-6.84%)

10/18/21 Deutsche Bank
PagSeguro concerns have no long-term impact, says Deutsche Bank
10/12/21 Goldman Sachs
PagSeguro recent selloff may be overdone, says Goldman Sachs
10/11/21 Citi
Brazil's proposed fee cap could remove 4% of PagSeguro revenue, says Citi
10/11/21 Bradesco BBI
Bradesco BBI says central bank news may raise perceived risk for PagSeguro
NYCB New York Community Bancorp
$12.82 /

-1.125 (-8.07%)

10/01/21 B. Riley
New York Community shares 'should re-rate higher,' says B. Riley
05/04/21 Raymond James
Flagstar Bancorp downgraded to Market Perform from Strong Buy at Raymond James
05/03/21 Deutsche Bank
New York Community Bancorp price target raised to $15 from $11.50 at Deutsche Bank
04/27/21 Wedbush
Flagstar Bancorp downgraded to Neutral from Outperform at Wedbush
FISV Fiserv
$98.86 /

-10.995 (-10.01%)

09/30/21
Fly Intel: Top five analyst initiations
09/30/21 William Blair
William Blair assumes Fiserv at Outperform on double-digit earnings growth
09/30/21 William Blair
Fiserv assumed with an Outperform at William Blair
08/19/21 Truist
ValueAct's reported SOTP argument for Fiserv 'doesn't hold water,' says Truist
ALKS Alkermes
$28.63 /

-2.89 (-9.17%)

13:41 Today Stifel
Alkermes price target raised to $29 from $25 at Stifel
10/06/21 Jefferies
Alkermes upgraded to Buy from Hold at Jefferies
09/27/21 BofA
Alkermes takeover thesis 'highly speculative,' says BofA
09/10/21 Mizuho
Alkermes price target raised to $36 from $33 at Mizuho
SIX Six Flags
$42.28 /

-3.83 (-8.31%)

07/26/21 Wedbush
Six Flags upgraded to Outperform at Wedbush ahead of inflection in story
07/26/21 Wedbush
Six Flags upgraded to Outperform from Neutral at Wedbush
06/21/21 B. Riley
B. Riley sees further share upside in theme park stocks after visits
05/21/21 Stifel
Stifel ups price target for 'most compelling' theme park Six Flags to $59
HOOD Robinhood
$35.43 /

-4.28 (-10.78%)

07:48 Today KeyBanc
Robinhood price target lowered to $50 from $55 at KeyBanc
07:42 Today JPMorgan
Robinhood price target lowered to $26 from $35 at JPMorgan
07:00 Today Barclays
Robinhood price target lowered to $42 from $50 at Barclays
06:47 Today Deutsche Bank
Robinhood price target lowered to $40 from $42 at Deutsche Bank
TWTR Twitter
$54.80 /

-6.735 (-10.95%)

09:18 Today Wedbush
Twitter price target lowered to $69 from $76 at Wedbush
08:10 Today Jefferies
Twitter price target lowered to $70 from $80 at Jefferies
07:56 Today MKM Partners
Twitter price target lowered to $77 from $83 at MKM Partners
07:50 Today KeyBanc
Twitter price target lowered to $70 from $81 at KeyBanc
BA Boeing
$206.57 /

-3.195 (-1.52%)

10/21/21 RBC Capital
Ducommun initiated with an Outperform at RBC Capital
10/21/21 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
10/21/21 RBC Capital
RBC starts Boeing at Outperform, sees attractive entry point
10/21/21 RBC Capital
Boeing initiated with an Outperform at RBC Capital
MCD McDonald's
$242.87 /

+6.455 (+2.73%)

10/14/21 Wells Fargo
McDonald's price target raised to $276 from $269 at Wells Fargo
10/05/21 Loop Capital
McDonald's initiated with a Buy at Loop Capital
10/05/21 Deutsche Bank
McDonald's price target raised to $265 ahead of Q3 at Deutsche Bank
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
V Visa
$215.78 /

-15.92 (-6.87%)

UPS UPS
$212.16 /

-5.9 (-2.71%)

TWTR Twitter
$54.80 /

-6.735 (-10.95%)

TSLA Tesla
$1,038.00 /

+20 (+1.96%)

STNE StoneCo
$33.84 /

-2.61 (-7.16%)

SQ Square
$253.09 /

-10.54 (-4.00%)

SIX Six Flags
$42.28 /

-3.83 (-8.31%)

RDS.A Royal Dutch Shell
$49.94 /

+1.09 (+2.23%)

PYPL PayPal
$234.89 /

-8.11 (-3.34%)

NYCB New York Community Bancorp
$12.82 /

-1.125 (-8.07%)

NET Cloudflare
$178.59 /

-6.62 (-3.57%)

MSFT Microsoft
$323.14 /

+13.3 (+4.29%)

MCD McDonald's
$242.87 /

+6.455 (+2.73%)

MAS Masco
$64.26 /

+3.13 (+5.12%)

KO Coca-Cola
$55.51 /

+1.05 (+1.93%)

HTZZ Hertz
$27.01 /

-0.44 (-1.60%)

HOOD Robinhood
$35.43 /

-4.28 (-10.78%)

HOG Harley-Davidson
$36.73 /

+1.23 (+3.46%)

GOOG Alphabet
$2,929.05 /

+132.96 (+4.76%)

GM General Motors
$54.25 /

-3.13 (-5.45%)

FISV Fiserv
$98.86 /

-10.995 (-10.01%)

FB Facebook
$312.23 /

-3.47 (-1.10%)

ETSY Etsy
$243.86 /

-4 (-1.61%)

ENPH Enphase Energy
$216.29 /

+42.83 (+24.69%)

CRTX Cortexyme
$13.31 /

-44.24 (-76.87%)

BA Boeing
$206.57 /

-3.195 (-1.52%)

AMZN Amazon.com
$3,393.47 /

+19.55 (+0.58%)

ALKS Alkermes
$28.63 /

-2.89 (-9.17%)

  • 27
    Oct
  • 29
    Jul
  • 30
    Apr
  • 10
    Dec
V Visa
$215.78 /

-15.92 (-6.87%)

UPS UPS
$212.16 /

-5.9 (-2.71%)

TWTR Twitter
$54.80 /

-6.735 (-10.95%)

TSLA Tesla
$1,038.00 /

+20 (+1.96%)

STNE StoneCo
$33.84 /

-2.61 (-7.16%)

SQ Square
$253.09 /

-10.54 (-4.00%)

SIX Six Flags
$42.28 /

-3.83 (-8.31%)

RDS.B Royal Dutch Shell
$49.68 /

+0.645 (+1.32%)

RDS.A Royal Dutch Shell
$49.94 /

+1.09 (+2.23%)

PYPL PayPal
$234.89 /

-8.11 (-3.34%)

NET Cloudflare
$178.59 /

-6.62 (-3.57%)

MSFT Microsoft
$323.14 /

+13.3 (+4.29%)

MCD McDonald's
$242.87 /

+6.455 (+2.73%)

KO Coca-Cola
$55.51 /

+1.05 (+1.93%)

HOOD Robinhood
$35.43 /

-4.28 (-10.78%)

GOOGL Alphabet Class A
$2,925.66 /

+136.025 (+4.88%)

GOOG Alphabet
$2,929.05 /

+132.96 (+4.76%)

GM General Motors
$54.25 /

-3.13 (-5.45%)

FISV Fiserv
$98.86 /

-10.995 (-10.01%)

FB Facebook
$312.23 /

-3.47 (-1.10%)

ETSY Etsy
$243.86 /

-4 (-1.61%)

DWAC Digital World Acquisition
$64.85 /

+6.1 (+10.38%)

BA Boeing
$206.57 /

-3.195 (-1.52%)

AMZN Amazon.com
$3,393.47 /

+19.55 (+0.58%)

V Visa
$215.78 /

-15.92 (-6.87%)

UPS UPS
$212.16 /

-5.9 (-2.71%)

TSLA Tesla
$1,038.00 /

+20 (+1.96%)

STNE StoneCo
$33.84 /

-2.61 (-7.16%)

SQ Square
$253.09 /

-10.54 (-4.00%)

SIX Six Flags
$42.28 /

-3.83 (-8.31%)

RDS.B Royal Dutch Shell
$49.68 /

+0.645 (+1.32%)

RDS.A Royal Dutch Shell
$49.94 /

+1.09 (+2.23%)

RDBX Redbox
$15.59 /

-0.26 (-1.64%)

PYPL PayPal
$234.89 /

-8.11 (-3.34%)

PAGS PagSeguro Digital
$36.10 /

-2.65 (-6.84%)

NYCB New York Community Bancorp
$12.82 /

-1.125 (-8.07%)

NET Cloudflare
$178.59 /

-6.62 (-3.57%)

MSFT Microsoft
$323.14 /

+13.3 (+4.29%)

MCD McDonald's
$242.87 /

+6.455 (+2.73%)

KO Coca-Cola
$55.51 /

+1.05 (+1.93%)

HTZZ Hertz
$27.01 /

-0.44 (-1.60%)

HOOD Robinhood
$35.43 /

-4.28 (-10.78%)

HOG Harley-Davidson
$36.73 /

+1.23 (+3.46%)

GOOGL Alphabet Class A
$2,925.66 /

+136.025 (+4.88%)

GOOG Alphabet
$2,929.05 /

+132.96 (+4.76%)

GM General Motors
$54.25 /

-3.13 (-5.45%)

FISV Fiserv
$98.86 /

-10.995 (-10.01%)

ETSY Etsy
$243.86 /

-4 (-1.61%)

ENPH Enphase Energy
$216.29 /

+42.83 (+24.69%)

DWAC Digital World Acquisition
$64.85 /

+6.1 (+10.38%)

BA Boeing
$206.57 /

-3.195 (-1.52%)

ALKS Alkermes
$28.63 /

-2.89 (-9.17%)

V Visa
$215.78 /

-15.92 (-6.87%)

UPS UPS
$212.16 /

-5.9 (-2.71%)

TWTR Twitter
$54.80 /

-6.735 (-10.95%)

TSLA Tesla
$1,038.00 /

+20 (+1.96%)

STNE StoneCo
$33.84 /

-2.61 (-7.16%)

SQ Square
$253.09 /

-10.54 (-4.00%)

PYPL PayPal
$234.89 /

-8.11 (-3.34%)

PAGS PagSeguro Digital
$36.10 /

-2.65 (-6.84%)

NET Cloudflare
$178.59 /

-6.62 (-3.57%)

MSFT Microsoft
$323.14 /

+13.3 (+4.29%)

MCD McDonald's
$242.87 /

+6.455 (+2.73%)

KO Coca-Cola
$55.51 /

+1.05 (+1.93%)

HTZZ Hertz
$27.01 /

-0.44 (-1.60%)

HOOD Robinhood
$35.43 /

-4.28 (-10.78%)

HOG Harley-Davidson
$36.73 /

+1.23 (+3.46%)

GOOGL Alphabet Class A
$2,925.66 /

+136.025 (+4.88%)

GM General Motors
$54.25 /

-3.13 (-5.45%)

FISV Fiserv
$98.86 /

-10.995 (-10.01%)

FB Facebook
$312.23 /

-3.47 (-1.10%)

ETSY Etsy
$243.86 /

-4 (-1.61%)

ENPH Enphase Energy
$216.29 /

+42.83 (+24.69%)

DWAC Digital World Acquisition
$64.85 /

+6.1 (+10.38%)

CRTX Cortexyme
$13.31 /

-44.24 (-76.87%)

BA Boeing
$206.57 /

-3.195 (-1.52%)

AMZN Amazon.com
$3,393.47 /

+19.55 (+0.58%)

Hot Stocks
Checkmate Pharmaceuticals appoints Alan Fuhrman interim CEO » 16:40
10/27/21
10/27
16:40
10/27/21
16:40
CMPI

Checkmate Pharmaceuticals

$3.92 /

-0.205 (-4.97%)

Checkmate Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPI Checkmate Pharmaceuticals
$3.92 /

-0.205 (-4.97%)

CMPI Checkmate Pharmaceuticals
$3.92 /

-0.205 (-4.97%)

10/14/21 BTIG
Checkmate Pharmaceuticals assumed with a Buy at BTIG
10/06/21 BofA
Checkmate Pharmaceuticals upgraded to Buy from Neutral at BofA
10/06/21 BofA
Checkmate Pharmaceuticals upgraded to Buy from Neutral at BofA
03/19/21 Jefferies
Checkmate Pharmaceuticals price target lowered to $19 from $23 at Jefferies
CMPI Checkmate Pharmaceuticals
$3.92 /

-0.205 (-4.97%)

Conference/Events
Humanigen management to meet virtually with Oppenheimer » 16:33
10/27/21
10/27
16:33
10/27/21
16:33
HGEN

Humanigen

$6.70 /

-0.275 (-3.94%)

Virtual Meeting to be…

Virtual Meeting to be held on November 3 hosted by Oppenheimer.

ShowHide Related Items >><<
HGEN Humanigen
$6.70 /

-0.275 (-3.94%)

HGEN Humanigen
$6.70 /

-0.275 (-3.94%)

09/10/21
Fly Intel: Top five analyst downgrades
09/10/21 Jefferies
Humanigen downgraded to Hold from Buy at Jefferies
09/09/21 Credit Suisse
Credit Suisse cuts Humanigen to Neutral after FDA denies lenzilumab EUA
09/09/21 Credit Suisse
Humanigen downgraded to Neutral from Outperform at Credit Suisse
HGEN Humanigen
$6.70 /

-0.275 (-3.94%)

  • 31
    Mar
HGEN Humanigen
$6.70 /

-0.275 (-3.94%)

HGEN Humanigen
$6.70 /

-0.275 (-3.94%)

Syndicate
Osmotica Pharmaceuticals files to sell 6.15M ordinary shares for holders  16:26
10/27/21
10/27
16:26
10/27/21
16:26
OSMT

Osmotica Pharmaceuticals

$1.82 /

-0.01 (-0.55%)

 
ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$1.82 /

-0.01 (-0.55%)

OSMT Osmotica Pharmaceuticals
$1.82 /

-0.01 (-0.55%)

10/11/21 Truist
Osmotica Pharmaceuticals price target lowered to $5 from $7 at Truist
09/24/21 Cantor Fitzgerald
Osmotica Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
09/24/21 Cantor Fitzgerald
Osmotica Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
04/06/21 RBC Capital
Osmotica Pharmaceuticals transferred with an Outperform at RBC Capital
OSMT Osmotica Pharmaceuticals
$1.82 /

-0.01 (-0.55%)

  • 07
    Oct
OSMT Osmotica Pharmaceuticals
$1.82 /

-0.01 (-0.55%)

OSMT Osmotica Pharmaceuticals
$1.82 /

-0.01 (-0.55%)

Hot Stocks
Alnylam says vutrisiran met all secondary endpoints in HELIOS-A Phase 3 study » 16:05
10/27/21
10/27
16:05
10/27/21
16:05
ALNY

Alnylam

$190.59 /

-7.19 (-3.64%)

Alnylam Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALNY Alnylam
$190.59 /

-7.19 (-3.64%)

ALNY Alnylam
$190.59 /

-7.19 (-3.64%)

10/04/21 UBS
Alnylam upgraded to Buy from Neutral at UBS
09/29/21 Piper Sandler
Pipeline captured in Alnylam's valuation, says Piper Sandler
08/27/21 BMO Capital
Alnylam price target raised to $196 from $174 at BMO Capital
08/04/21 Barclays
Alnylam price target raised to $216 from $196 at Barclays
ALNY Alnylam
$190.59 /

-7.19 (-3.64%)

ALNY Alnylam
$190.59 /

-7.19 (-3.64%)

Syndicate
CohBar files to sell common stock and warrants, no amount given » 16:02
10/27/21
10/27
16:02
10/27/21
16:02
CWBR

CohBar

/

+

Cantor Fitzgerald &…

Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering, and Brookline Capital Markets, a division of Arcadia Securities, LLC, is acting as co-manager.

ShowHide Related Items >><<
CWBR CohBar
/

+

CWBR CohBar
/

+

08/11/21 WBB Securities
CohBar upgraded to Buy from Speculative Buy at WBB Securities
04/23/21 Maxim
CohBar initiated with a Buy at Maxim
04/23/21 Maxim
CohBar initiated with a Buy at Maxim
03/31/21 Chardan
CohBar price target raised to $3.50 from $3.00 at Chardan
CWBR CohBar
/

+

Options
Sorrento Therapeutics call volume above normal and directionally bullish » 14:45
10/27/21
10/27
14:45
10/27/21
14:45
SRNE

Sorrento Therapeutics

$7.13 /

+0.4 (+5.94%)

Bullish option flow…

Bullish option flow detected in Sorrento Therapeutics with 16,345 calls trading, 2x expected, and implied vol increasing over 2 points to 78.76%. 10/29 weekly 7.5 calls and 11/5 weekly 7.5 calls are the most active options, with total volume in those strikes near 7,200 contracts. The Put/Call Ratio is 0.05. Earnings are expected on November 5th.

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$7.13 /

+0.4 (+5.94%)

SRNE Sorrento Therapeutics
$7.13 /

+0.4 (+5.94%)

08/09/21 H.C. Wainwright
Sorrento Therapeutics price target lowered to $26 from $30 at H.C. Wainwright
03/26/21 B. Riley
Sorrento data make case for expedited EUA filing path, says B. Riley Securities
01/29/21 B. Riley
Sorrento Therapeutics initiated with a Buy at B. Riley Securities
01/21/21 Alliance Global Partners
Sorrento Therapeutics initiated with a Buy at Alliance Global Partners
SRNE Sorrento Therapeutics
$7.13 /

+0.4 (+5.94%)

SRNE Sorrento Therapeutics
$7.13 /

+0.4 (+5.94%)

SRNE Sorrento Therapeutics
$7.13 /

+0.4 (+5.94%)

Hot Stocks
Sorrento reports 'positive' preliminary results from Phase 2 Abivertinib studies » 14:28
10/27/21
10/27
14:28
10/27/21
14:28
SRNE

Sorrento Therapeutics

$7.02 /

+0.29 (+4.31%)

Sorrento Therapeutics…

Sorrento Therapeutics announced positive preliminary results from two Phase 2 studies designed to identify the hospitalized patient population suffering from COVID-19-induced pneumonia and respiratory depression likely to respond to treatment with oral Abivertinib. Abivertinib is a novel small molecule tyrosine kinase inhibitor that selectively targets both mutant forms of the epidermal growth factor receptor as well as Bruton's tyrosine kinase. Abivertinib irreversibly binds to the BTK receptor, preventing the phosphorylation of the receptor. Due to this effect, it has shown potent immunomodulatory activities in vitro with potent inhibition of key pro-inflammatory cytokine production, including IL-1 beta, IL-6 and TNF-alpha. These cytokines are associated with acute respiratory distress syndrome, and with cytokine release syndrome or cytokine storm, and COVID-19 disease progression with poor outcomes in patients. In the US Abivertinib study, most patients were sicker at baseline with patients in the Abivertinib group skewed to sicker or worse severity by clinical status and by oxygenation status. In the Brazil Abivertinib study, only 8% were in category 5, demonstrating a far less severely compromised population having been enrolled. In the US study, patients in category 5 showed a 20% improvement in the primary endpoint, and in the Brazil study, a 25% improvement. In the US study, patients in category 5 treated with Abivertinib were discharged from the hospital 2 days sooner than those in the Control Group. Overall, in both studies patients who were in category 5, but not in category less than 4, showed improvement with Abivertinib treatment. Based upon these preliminary results, a pivotal multi-country, multi-center pivotal Phase 3 study is being planned in 400 patients on the At-Risk Hospitalized COVID-19 Patients requiring oxygen support via non-invasive ventilation or high flow oxygen at baseline. "Patients on non-invasive ventilation or high flow oxygen supplementation due to COVID-19-induced respiratory failure represent a sicker and at-risk population with few available treatment options," stated Dr. Mike Royal, Chief Medical Officer of Sorrento Therapeutics. "Abivertinib has the potential to fill this unmet need and significantly reduce progression to intubation, mechanical ventilation and death."

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$7.02 /

+0.29 (+4.31%)

SRNE Sorrento Therapeutics
$7.02 /

+0.29 (+4.31%)

08/09/21 H.C. Wainwright
Sorrento Therapeutics price target lowered to $26 from $30 at H.C. Wainwright
03/26/21 B. Riley
Sorrento data make case for expedited EUA filing path, says B. Riley Securities
01/29/21 B. Riley
Sorrento Therapeutics initiated with a Buy at B. Riley Securities
01/21/21 Alliance Global Partners
Sorrento Therapeutics initiated with a Buy at Alliance Global Partners
SRNE Sorrento Therapeutics
$7.02 /

+0.29 (+4.31%)

SRNE Sorrento Therapeutics
$7.02 /

+0.29 (+4.31%)

SRNE Sorrento Therapeutics
$7.02 /

+0.29 (+4.31%)

Hot Stocks
Jounce initiated patient enrollment in INNATE cohorts for JTX-8064 on Oct. 7 » 14:15
10/27/21
10/27
14:15
10/27/21
14:15
JNCE

Jounce Therapeutics

$8.76 /

-0.13 (-1.46%)

Previously, on October 7,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$8.76 /

-0.13 (-1.46%)

JNCE Jounce Therapeutics
$8.76 /

-0.13 (-1.46%)

09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform with $10 target at Raymond James
09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform from Market Perform at Raymond James
08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
JNCE Jounce Therapeutics
$8.76 /

-0.13 (-1.46%)

  • 10
    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.